These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 5564043)

  • 1. Human lymphocyte antigen reactivity modified by neuraminidase.
    Grothaus EA; Flye MW; Yunis E; Amos DB
    Science; 1971 Aug; 173(3996):542-4. PubMed ID: 5564043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbohydrate inhibition studies of the naturally occurring human antibody to neuraminidase-treated human lymphocytes.
    Rogentine GN; Plocinik BA
    J Immunol; 1974 Sep; 113(3):848-58. PubMed ID: 4528455
    [No Abstract]   [Full Text] [Related]  

  • 3. The complement-binding and absorptive capacity of human white blood cells treated with neuraminidase.
    Reisner EG; Amos DB
    Transplantation; 1972 Oct; 14(4):455-61. PubMed ID: 4404957
    [No Abstract]   [Full Text] [Related]  

  • 4. Unmasking of xenogeneic neo-antigens on mouse lymphoid cell surfaces by Vibrio cholerae neuraminidase.
    Ray PK; Simmons RL
    Proc Soc Exp Biol Med; 1973 Jan; 142(1):217-22. PubMed ID: 4118961
    [No Abstract]   [Full Text] [Related]  

  • 5. Failure of neuraminidase to unmask allogeneic antigens on cell surfaces.
    Ray PK; Simmons RL
    Proc Soc Exp Biol Med; 1971 Nov; 138(2):600-4. PubMed ID: 5118473
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of neuraminidase on serological properties of murine lymphoid cells.
    Schlesinger M; Amos BD
    Transplant Proc; 1971 Mar; 3(1):895-7. PubMed ID: 4106346
    [No Abstract]   [Full Text] [Related]  

  • 7. [The effect of heating and drugs on HL-A antigens and their reactions with cytotoxins].
    Májský A; Machácková M; Fiserová V; Hyánková M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1975; 102(6):656-70. PubMed ID: 54317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxicity reactions during immunotherapy of melanoma with neuraminidase altered autologous tumor cells.
    Miller EE; Rosato FE; Brown AS; Moskovitz A; Johnson J
    J Surg Oncol; 1976; 8(1):31-4. PubMed ID: 1249939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuraminidase reversal of resistance to lysis of herpes simplex virus-infected cells by antibody and complement.
    Tompkins WA; Seth P; Gee S; Rawls WE
    J Immunol; 1976 Feb; 116(2):489-95. PubMed ID: 175118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of neuraminidase on the stimulatory capacity of cells in human mixed lymphocyte cultures.
    Lundgren G; Simmons RL
    Clin Exp Immunol; 1971 Dec; 9(6):915-26. PubMed ID: 4110358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of neuraminidase induced antigen "unmasking".
    Simmons RL; Rios A; Ray PK
    Surg Forum; 1970; 21():265-7. PubMed ID: 4936981
    [No Abstract]   [Full Text] [Related]  

  • 12. Natural human antibodies to "hidden" membrane components.
    Rosenberg SA; Rogentine GN
    Nat New Biol; 1972 Oct; 239(94):203-4. PubMed ID: 4507729
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of neuraminidase on the sensitivity of tumor cells toward lysis by antibody and complement or by sensitized lymphocytes.
    Turianskyj FH; Gyenes L
    Transplantation; 1976 Jul; 22(1):24-30. PubMed ID: 59438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Murine autoantibodies to a cryptic membrane antigen; possible explanation for neuraminidase-induced increase in cell immunogenicity.
    Rosenberg SA; Schwarz S
    J Natl Cancer Inst; 1974 Apr; 52(4):1151-5. PubMed ID: 4826586
    [No Abstract]   [Full Text] [Related]  

  • 15. [Practical interest of a micromethod for neuraminidase treatment of lymphocytes in transplantation immunology (author's transl)].
    de Mouzon A; Ohayon E; Durand D; Ducos J
    Pathol Biol (Paris); 1976 Dec; 24(10):685-9. PubMed ID: 796790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of mixed lymphocyte reactivity by neuraminidase.
    Han T
    Transplantation; 1972 Oct; 14(4):514-7. PubMed ID: 4118728
    [No Abstract]   [Full Text] [Related]  

  • 17. Neuraminidase alteration of human lymphocyte reactivity to mitogens, antigens and allogenic lymphocytes.
    Pauly JL; Germain MJ; Han T
    J Med; 1978; 9(3):223-36. PubMed ID: 283169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lymphocytes HLA antigens expressivity after neuraminidase treatment (author's transl)].
    de Mouzon A; Ohayon E; Oksman-Domejean F; Ducos J
    Ann Immunol (Paris); 1976; 127(5):687-701. PubMed ID: 984732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alteration of the HL-A antigenic site in situ.
    Gauldie J; Bhandari SC; Singal DP
    Immunol Commun; 1975; 4(5):465-76. PubMed ID: 54332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of heterologous antilymphocyte serum on human lymphocyte cytotoxicity in vitro.
    Lundgren G
    Surg Forum; 1969; 20():241-3. PubMed ID: 5393626
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.